Clinical trials
Progression clinical trials
Below are recruiting progression clinical trials, each written for real people, not researchers. We’re tracking 716 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07841470RecruitingPhase 2/Phase 3
Corneal crosslinking for progressive keratoconus or corneal ectasia
This study tests a procedure called corneal crosslinking to slow or stop the progression of keratoconus or corneal ectasia. It might help keep your cornea stable and prevent further vision loss.
Indianapolis, IndianaAges 10–90 - NCT04893785RecruitingPhase 2
Cabozantinib plus temozolomide for advanced neuroendocrine lung tumors
This Phase 2 study tests whether combining cabozantinib with temozolomide can control advanced lung or gastrointestinal neuroendocrine tumors that have grown after prior treatments. It also closely monitors safety, including blood counts, organ function, and other side effects.
Naples, CampaniaAges 18 years+ - NCT06472388RecruitingPhase 2
Testing two doses of everolimus for neuroendocrine tumors
This trial compares two daily doses (5 mg vs 10 mg) of everolimus, a targeted therapy, to see which works better and is safer for people with advanced neuroendocrine tumors (NETs). You may qualify if your cancer has grown despite previous treatment and you are in relatively good health.
São Paulo, São PauloAges 16 years+ - NCT07817550Enrolling by invitation
Predicting sudden health declines with wearable monitors
This study uses wearable devices and other monitoring tools to see if they can predict when a patient might suddenly get worse within the next 72 hours. By participating, you may help develop early warning systems that could lead to faster medical help.
New York, New YorkAges 18–90 - NCT07824921Enrolling by invitation
Oral microbiome in aorta aneurysm and carotid atherosclerosis
This study looks at how bacteria in your mouth might be linked to the health of your blood vessels. It may help doctors understand why some people get aneurysms or blocked arteries, and could lead to better ways to prevent or treat these conditions.
BudapestAges 18–110 - NCT07820254Recruiting
How well people with pulmonary fibrosis can breathe in
This study looks at how well people with pulmonary fibrosis can breathe in and aims to see if their breathing flow rate is linked to their condition. It may help doctors understand more about the disease and plan better care.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06488547Recruiting
Stress and muscle health study for Greek workers
This trial looks at how stress affects muscle and bone health in employees. If you join, you'll answer questions and be measured with simple electronic devices. The goal is to find ways to help workers stay healthy.
Larissa, Biopolis- LarissaAges 19 years+ - NCT06487429RecruitingPhase 2
Short radiation followed by combo therapy for HER2+ stomach cancer
This trial tests a new approach for stomach cancer that has spread to nearby tissues but not to other organs. You would get a short course of radiation, followed by a combination of targeted therapy (Disitamab Vedotin), chemotherapy (S-1), and immunotherapy (Sintilimab) before surgery to shrink the tumor and improve outcomes.
Wuhan, HubeiAges 18–75 - NCT07810478Recruiting
Comparing rehab programs after shin surgery
This study compares two different rehabilitation programs after surgery for a shin (tibia) fracture. The goal is to find out which program helps you recover better and faster.
Gaza, Gaza StripAges 18–60 - NCT06501950Recruiting
Measuring silent MS progression with advanced tests
This study is looking for people with MS who are already on a monoclonal antibody therapy. It aims to measure subtle signs of disease progression using advanced tests, even if you feel stable.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT06498947Recruiting
Understanding Natural Farsightedness in Kids
This study looks at natural changes in children's eyes that cause mild farsightedness (called "physiological hyperopia") in 6- to 9-year-olds. It aims to understand why some children have this harmless vision difference, which may help with future eye care.
Beijing, Beijing MunicipalityAges 6–9 - NCT07805967Recruiting
Study of rare parkinsonian conditions
This study follows people with certain rare brain conditions that affect movement and thinking, such as multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration. It aims to learn more about how these conditions progress over time, which may help improve future care.
Changshu, JiangsuAges 18 years+ - NCT07794579RecruitingPhase 3
Study of orforglipron for people with overweight at risk of health problems
This trial tests a new medicine, orforglipron, to help people with overweight who are at risk of developing weight-related health issues. It aims to see if the medicine can help with weight management and reduce risks before more serious conditions develop.
Anniston, AlabamaAges 18 years+ - NCT07793916Recruiting
Heart device and tricuspid valve function study
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
Seoul, SeoulAges 19 years+ - NCT06529549Recruiting
Organoid drug test for advanced prostate cancer
This trial uses a lab test on a tiny sample of your tumor (called an organoid) to find which drug might work best for your advanced prostate cancer. It's for men whose cancer has stopped responding to hormone therapy and got worse after first treatment.
Guangzhou, GuangdongAges 18–75 - NCT07786116Recruiting
Gut bacteria in Parkinson's disease and related conditions
This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.
Cambridge, CB2Ages 55 years+ - NCT07779005Recruiting
Lung cancer risk factors study
This study is looking at people who have been newly diagnosed with lung cancer to learn more about what causes it and how it progresses. By participating, you can help researchers find better ways to prevent and treat this disease.
Shenyang, LiaoningAges 18–75 - NCT07775235Recruiting
Treatment outcomes for muscle inflammation with rapid lung disease
This study looks at how well treatments work for people with muscle inflammation (myositis) that causes a fast-progressing lung condition. It may help doctors find better ways to manage this serious combination.
SingaporeAges 21 years+ - NCT06523673RecruitingPhase 3
SBRT for lung cancer with limited new growth
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
Hangzhou, ZhejiangAges 18 years+ - NCT07762573Recruiting
Predicting COPD progression with dynamic chest x-rays
This study looks at whether a special type of chest x-ray (called dynamic chest radiography) can help predict how chronic obstructive pulmonary disease (COPD) might progress. It may help doctors better understand the disease and plan treatment.
Guangzhou, GuangdongAges 30–85 - NCT07764081Recruiting
Tracking coronary artery aneurysms and their care
This study tracks people who have a coronary artery aneurysm, a bulging area in a heart artery, to learn how it progresses and how it is managed. By participating, you'll help researchers understand the condition better, which may lead to improved care.
Nanjing, JiangsuAges 18–80 - NCT07754097Recruiting
Tracking your health at home for chronic kidney disease
This study tests if regularly tracking your blood pressure, diet, and medications through a mobile app can help monitor kidney disease progression. It aims to see if this self-management approach helps you stay healthier.
Daejeon, DJAges 19–84 - NCT07752030Enrolling by invitation
Measuring treatment effects in cerebral palsy
This study looks at how well different treatments work for people with cerebral palsy. It may help doctors understand which treatments are best for improving walking and movement.
Omaha, NebraskaAges 16–30 - NCT07750249Enrolling by invitationEarly Phase 1
Short-chain fatty acids for IgA nephropathy
This trial tests whether a daily supplement of short-chain fatty acids (SCFAs) can slow down kidney damage in people with IgA nephropathy. SCFAs are substances made by gut bacteria that may help reduce inflammation and protect the kidneys.
MartinAges 18 years+
Hear when a new Progression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for progression?
- Yes. Clin2 currently lists 716 recruiting progression studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a progression trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a progression trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.